Table 1

 Clinical details and experimental results for each individual case

PatientMean visibleMean invisibleGenderAgeVintageHemisphereLesion
The following details are given: mean proportion of targets cancelled with visible or invisible marks; gender and age; approximate vintage (when known) of lesion, plus its laterality and site as revealed by CT or MRI.
BG, basal ganglia; EC, external capsule; F, frontal; IC, internal capsule; Inf, infarction; Hr, haemorrhage; O, occipital; P, parietal; SC, subcortical.
Cases are ordered here by experimental result, with case 1 showing the largest increase in neglect for invisible versus visible cancellation, case 2 next largest, and so on.
10.950.66M783 monthsRPO and posterior F; Hr
20.670.48F2 weeksRSC(EC); Hr
30.970.81M566 weeksRP, SC; Inf
40.920.76M642 monthsRPF; Inf
50.890.73M5910 monthsRSC (IC+BG)+inferior T; Hr
60.950.80M592 monthsRSC; Inf
70.950.81F40>1 yearRP (post-surgery for cyst)
80.770.66M62>1 yearRP (post-surgery for meningioma)
90.990.90M697 monthsRPF; Inf
101.000.94M763 weeksRP; Hr
110.140.07M713 monthsRPO; Inf
120.910.86M6512 monthsRPO; Hr
130.430.39M674 monthsRSC (IC); Inf
140.610.59F462 weeksRSC; aneurysm (subarachnoid)
150.150.13M663 monthsLPFO; Inf
161.000.99M722 monthsLF; Inf
170.990.99M611 monthLSC (thalamic lacunar); Inf
180.500.50F656 monthRPF; Inf
190.140.14M783 weeksRPO; Hr
200.970.98M876 monthsRP; Hr
210.330.36M682 weeksRPFT; Hr
220.760.79M687 monthsRPT; Inf
230.780.81M787 monthsRPF; Inf